Hyundai Bioscience Co (XKRX:048410) Other Long Term Assets : ₩3,602 Mil (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Hyundai Bioscience Co Other Long Term Assets?

Hyundai Bioscience Co's other long-term assets for the quarter that ended in Mar. 2024 was ₩3,602 Mil.

Hyundai Bioscience Co's quarterly other long-term assets increased from Sep. 2023 (₩2,681 Mil) to Dec. 2023 (₩3,556 Mil) and increased from Dec. 2023 (₩3,556 Mil) to Mar. 2024 (₩3,602 Mil).

Hyundai Bioscience Co's annual other long-term assets declined from Dec. 2021 (₩5,323 Mil) to Dec. 2022 (₩3,147 Mil) but then increased from Dec. 2022 (₩3,147 Mil) to Dec. 2023 (₩3,556 Mil).

Hyundai Bioscience Co Other Long Term Assets Historical Data

The historical data trend for Hyundai Bioscience Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Bioscience Co Other Long Term Assets Chart

Hyundai Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

3,752.25

5,195.09

5,322.50

3,146.67

3,555.51

Hyundai Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															3,080.32	2,815.38	2,680.93	3,555.51	3,602.34

Hyundai Bioscience Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Hyundai Bioscience Co (XKRX:048410) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hyundai Bioscience Co Ltd (XKRX:048410) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

150 North-Ahyun Road, 3rd Floor Academic Cooperation Building, Ehwa Women’s University, Seodaemun-gu, Seoul, KOR

Website

http://www.hyundaibioscience.com

Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.

Hyundai Bioscience Co (XKRX:048410) Headlines

No Headlines